Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Lab Automation In Drug Discovery Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The lab automation in drug discovery market has experienced significant expansion in recent years. It is projected to grow from $6.77 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be attributed to several factors, including the adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, an increased demand for automation to minimize errors, the integration of lab information management systems, and the growth in high-throughput screening technologies.
The lab automation in drug discovery market is projected for substantial expansion in the coming years. It is anticipated to reach $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This expected growth during the forecast period is driven by several factors, including the expansion of AI-driven drug discovery platforms, a growing demand for personalized medicine, the emergence of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharmaceutical and biotechnology companies. Prominent trends anticipated in this period feature high-throughput screening automation, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.
Get A Free Sample Report With In-Depth Market Insights:
Lab Automation In Drug Discovery Market Growth Factors: What’s Supporting Expansion?
The escalating need for precision medicine is projected to stimulate the expansion of lab automation within the drug discovery market moving forward. Precision medicine, also known as personalized medicine, is a method for medical treatment and prevention that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation quickens research, enhances experimental consistency, and improves the efficiency of precision medicine and drug discovery workflows, ultimately contributing to the development of more effective medications and diagnostics tailored for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized therapies for patients with rare diseases, which was a considerable increase from the six approved in 2022. Thus, the heightened demand for precision medicine is propelling the growth of lab automation in the drug discovery market.
Lab Automation In Drug Discovery Market Segment Landscape: Which Areas Lead Development?
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
Lab Automation In Drug Discovery Market Industry Trends: What’s Reshaping Demand?
Major companies engaged in lab automation within the drug discovery market are focusing on integrating AI-driven and robotics-based platforms to accelerate formulation development and improve R&D efficiency. These AI-powered and robot-assisted platforms leverage smart algorithms and automated machines to streamline tasks, enhance precision, and speed up workflows. For example, in May 2025, Intrepid Labs, a research laboratory based in Canada, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically accelerate drug formulation development. Backed by over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.
Lab Automation In Drug Discovery Market Industry Leaders And Competitive Landscape
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation
View The Full Lab Automation In Drug Discovery Market Report:
Lab Automation In Drug Discovery Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
